Improving glaucoma management with advanced imaging technology
Clinical glaucoma management enabled by visible-light OCT
['FUNDING_U01'] · NORTHWESTERN UNIVERSITY · NIH-10886755
This study is testing a new imaging technique called visible-light optical coherence tomography (vis-OCT) to help doctors spot early signs of glaucoma, so patients can get better and faster care for their eye health.
Quick facts
| Phase | ['FUNDING_U01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | NORTHWESTERN UNIVERSITY (nih funded) |
| Locations | 1 site (Chicago, UNITED STATES) |
| Trial ID | NIH-10886755 on ClinicalTrials.gov |
What this research studies
This research aims to develop a new imaging technique called visible-light optical coherence tomography (vis-OCT) to enhance the diagnosis and management of glaucoma. By measuring the structure of retinal layers and assessing oxygen levels in the retina, the study seeks to identify early signs of glaucoma that are often missed by traditional methods. Patients will benefit from more accurate assessments of their condition, potentially leading to earlier interventions and better outcomes. The research involves collaboration among experts in technology and clinical management to validate the effectiveness of this new tool.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with glaucoma or those at high risk for developing the condition.
Not a fit: Patients with advanced glaucoma who have already experienced significant vision loss may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier detection and better management of glaucoma, improving patient outcomes.
How similar studies have performed: Other research has shown promise in using advanced imaging techniques for glaucoma management, suggesting that this approach could be effective.
Where this research is happening
Chicago, UNITED STATES
- NORTHWESTERN UNIVERSITY — Chicago, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: ZHANG, HAO F — NORTHWESTERN UNIVERSITY
- Study coordinator: ZHANG, HAO F
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.